Skip to content
The Great News – Lifestyle
Home
Sample Page
Author:
Olema Oncology
Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting
May 21, 2026
Olema Oncology to Participate in Upcoming Investor Conferences
May 19, 2026
Olema Oncology Reports First Quarter 2026 Financial and Operating Results
May 12, 2026
←
Previous Page
1
2